[1] Wartofsky L. Radioiodine therapy for Graves'disease: case selection and restrictions recommended to patients in North America. Thyroid, 1997, 7(2): 213-216.  doi: 10.1089/thy.1997.7.213
[2]

中华医学会. 临床技术操作规范(核医学分册). 北京: 人民军医出版社, 2004: 175-177.
[3] 马寄晓. 放射性核素治疗的现状与进展. 中华核医学杂志, 1984, 4(1): 1-3.
[4] Rivkees SA, Sklar C, Freemark M. Clinical review 99: The manage-ment of Graves'disease in children, with special emphasis on radio-iodine treatment. J Clin Endocrinol Metab, 1998, 83(11): 3767-3776.
[5] 段东, 罗加, 倪济苍, 等. 青少年甲亢131I治疗的临床初探. 重庆医科大学学报, 2002, 27(1): 96-99.
[6] Rivkees SA, Cornelius EA. Influence of iodion-131 dose on the out-come of hyperthyroidism in children. Pediatrics, 2003, 111(4): 745-749.  doi: 10.1542/peds.111.4.745
[7] Read CH Jr, Tansey MJ, Menda Y. A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves'patients. JClin Endocrinol Metab, 2004, 89(9): 4229-4233.  doi: 10.1210/jc.2003-031223